Ria Roelandt

4.1k total citations · 2 hit papers
22 papers, 2.9k citations indexed

About

Ria Roelandt is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Ria Roelandt has authored 22 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in Ria Roelandt's work include Cell death mechanisms and regulation (8 papers), interferon and immune responses (5 papers) and Inflammasome and immune disorders (5 papers). Ria Roelandt is often cited by papers focused on Cell death mechanisms and regulation (8 papers), interferon and immune responses (5 papers) and Inflammasome and immune disorders (5 papers). Ria Roelandt collaborates with scholars based in Belgium, United States and Germany. Ria Roelandt's co-authors include Peter Vandenabeele, Wim Declercq, Mathieu J.M. Bertrand, Inge Bruggeman, Nozomi Takahashi, Kathrin Weber, Yves Dondelinger, Tom Vanden Berghe, Saskia Lippens and Amanda Gonçalves and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Ria Roelandt

22 papers receiving 2.9k citations

Hit Papers

MLKL Compromises Plasma Membrane Integrity by Binding to ... 2010 2026 2015 2020 2014 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ria Roelandt Belgium 15 2.0k 911 800 381 302 22 2.9k
Frédéric Luciano France 31 2.8k 1.4× 1.2k 1.3× 859 1.1× 492 1.3× 357 1.2× 56 4.3k
Hamid Kashkar Germany 34 2.5k 1.2× 1.0k 1.1× 544 0.7× 273 0.7× 447 1.5× 73 3.7k
Shun Kageyama Japan 18 1.7k 0.8× 618 0.7× 1.5k 1.8× 520 1.4× 211 0.7× 30 3.0k
James E. Sligh United States 18 1.5k 0.7× 565 0.6× 381 0.5× 146 0.4× 185 0.6× 34 2.6k
Irene L. Ch’en United States 13 2.1k 1.0× 1.4k 1.5× 447 0.6× 169 0.4× 411 1.4× 16 2.9k
Mohamed Hassan Germany 29 1.3k 0.7× 388 0.4× 470 0.6× 261 0.7× 280 0.9× 86 2.5k
Mohamed Lamkanfi Belgium 21 2.1k 1.1× 981 1.1× 365 0.5× 194 0.5× 254 0.8× 31 3.1k
Honglei Weng Germany 32 1.2k 0.6× 468 0.5× 1.1k 1.4× 215 0.6× 266 0.9× 79 3.2k
Claus Kerkhoff Germany 30 2.4k 1.2× 1.3k 1.5× 345 0.4× 162 0.4× 573 1.9× 59 3.3k
Juan Lin China 12 2.5k 1.2× 1.5k 1.7× 679 0.8× 161 0.4× 413 1.4× 25 3.5k

Countries citing papers authored by Ria Roelandt

Since Specialization
Citations

This map shows the geographic impact of Ria Roelandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ria Roelandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ria Roelandt more than expected).

Fields of papers citing papers by Ria Roelandt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ria Roelandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ria Roelandt. The network helps show where Ria Roelandt may publish in the future.

Co-authorship network of co-authors of Ria Roelandt

This figure shows the co-authorship network connecting the top 25 collaborators of Ria Roelandt. A scholar is included among the top collaborators of Ria Roelandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ria Roelandt. Ria Roelandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seurinck, Ruth, Samya Van Coillie, Sze Men Choi, et al.. (2025). Potential of biomarker-based enrichment strategies to identify critically ill patients for emerging cell death interventions. Cell Death and Differentiation. 32(12). 2284–2293. 2 indexed citations
2.
Verstraeten, Bruno, Jessica Vetters, Tatyana Divert, et al.. (2024). Type 1 immunity enables neonatal thymic ILC1 production. Science Advances. 10(3). eadh5520–eadh5520. 4 indexed citations
3.
Maueröder, Christian, Bruno Verstraeten, Tatyana Divert, et al.. (2024). TL1A and IL-18 synergy promotes GM-CSF-dependent thymic granulopoiesis in mice. Cellular and Molecular Immunology. 21(8). 807–825. 3 indexed citations
4.
Peleman, Cédric, Samya Van Coillie, Symen Ligthart, et al.. (2023). Ferroptosis and pyroptosis signatures in critical COVID-19 patients. Cell Death and Differentiation. 30(9). 2066–2077. 30 indexed citations
5.
Ghazavi, Farzaneh, Stephanie Schulz, Sofie Martens, et al.. (2022). Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state. Proceedings of the National Academy of Sciences. 119(6). 14 indexed citations
6.
Martens, Sofie, et al.. (2021). MLKL in cancer: more than a necroptosis regulator. Cell Death and Differentiation. 28(6). 1757–1772. 121 indexed citations
7.
Roelandt, Ria, et al.. (2021). Punching Holes in Cellular Membranes: Biology and Evolution of Gasdermins. Trends in Cell Biology. 31(6). 500–513. 99 indexed citations
8.
Dondelinger, Yves, Tom Delanghe, Dario Priem, et al.. (2019). Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation. Nature Communications. 10(1). 1729–1729. 139 indexed citations
9.
Tanç, Muhammet, Ammar Kurdi, Ria Roelandt, et al.. (2019). Synthesis and evaluation of novel benzotropolones as Atg4B inhibiting autophagy blockers. Bioorganic Chemistry. 87. 163–168. 12 indexed citations
10.
Weber, Kathrin, Ria Roelandt, Inge Bruggeman, Yann Estornes, & Peter Vandenabeele. (2018). Nuclear RIPK3 and MLKL contribute to cytosolic necrosome formation and necroptosis. Communications Biology. 1(1). 6–6. 129 indexed citations
11.
Rojas‐Rivera, Diego, Tinneke Delvaeye, Ria Roelandt, et al.. (2017). When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157. Cell Death and Differentiation. 24(6). 1100–1110. 157 indexed citations
12.
Grootaert, Mandy O. J., Ria Roelandt, Jurgen Joossens, et al.. (2016). Inhibitor screening and enzymatic activity determination for autophagy target Atg4B using a gel electrophoresis-based assay. European Journal of Medicinal Chemistry. 123. 631–638. 12 indexed citations
13.
Berghe, Tom Vanden, Dieter Demon, Pieter Bogaert, et al.. (2014). Simultaneous Targeting of IL-1 and IL-18 Is Required for Protection against Inflammatory and Septic Shock. American Journal of Respiratory and Critical Care Medicine. 189(3). 282–291. 136 indexed citations
14.
Quimbaya, Mauricio, Eric Raspé, Geertrui Denecker, et al.. (2014). Deregulation of the Replisome Factor MCMBP Prompts Oncogenesis in Colorectal Carcinomas through Chromosomal Instability. Neoplasia. 16(9). 694–709. 10 indexed citations
15.
Dondelinger, Yves, Wim Declercq, Sylvie Montessuit, et al.. (2014). MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates. Cell Reports. 7(4). 971–981. 663 indexed citations breakdown →
16.
Remijsen, Quinten, Vera Goossens, Sasker Grootjans, et al.. (2014). Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis. Cell Death and Disease. 5(1). e1004–e1004. 168 indexed citations
17.
Takahashi, Nozomi, Linde Duprez, Sasker Grootjans, et al.. (2012). Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death and Disease. 3(11). e437–e437. 369 indexed citations
18.
Bertrand, Mathieu J.M., Saskia Lippens, An Staes, et al.. (2011). cIAP1/2 Are Direct E3 Ligases Conjugating Diverse Types of Ubiquitin Chains to Receptor Interacting Proteins Kinases 1 to 4 (RIP1–4). PLoS ONE. 6(9). e22356–e22356. 93 indexed citations
19.
Hoste, Esther, P. M. J. H. Kemperman, Michaël Devos, et al.. (2011). Caspase-14 Is Required for Filaggrin Degradation to Natural Moisturizing Factors in the Skin. Journal of Investigative Dermatology. 131(11). 2233–2241. 153 indexed citations
20.
Wirawan, Ellen, Lieselotte Vande Walle, Kristof Kersse, et al.. (2010). Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death and Disease. 1(1). e18–e18. 551 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026